Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,514.84
(
0.20%
)
News Focus
News Focus
Post# of 828166
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

joeycav11

Send PM Follow Ignore
Followers 27
Posts 751
Boards Moderated 0
Alias Born 11/22/2014

joeycav11

Member Level

Re: CrashOverride post# 520141

Saturday, 10/08/2022 2:25:11 AM

Saturday, October 08, 2022 2:25:11 AM

Post# of 828166
Thanks Crash, The British are pragmatic and they will approve a new therapy with efficacy and no side effects...
Dc Vax had groundbreaking trial results and it has the potential for even more amazing eficacy with combination of polyi icl and or maybe keytruda.
Britian was smart not to fund the helmet and their sketchy survival data.
And I think the money is there for Nice approvoal but I believe it has to be coordinated with flashworks approvoal.
Its all about being able to meet the demand. And nwbo is counting on manufacturing approvoal for the new device in Britian first.
Good luck friends!


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News